• Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

Novo Nordisk to Replace C.E.O. After Losing Edge in Weight-Loss Drugs

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Appointments and Executive Changes, Drugs (Pharmaceuticals), GLP-1 RAs (Drug), Jorgensen, Lars Fruergaard, Novo Nordisk A/S, Ozempic (Drug), Stocks and Bonds
←Why Everything Is ‘Coded’ Now
Who Took the ‘Napalm Girl’ Photo?→

More posts

  • White House Correspondents’ Dinner Shooting Suspect Seen in Ambulance

  • Will you have an ‘extra’ payday in May? Here’s how to tell

  • Congress must deliver substantive health care reform in 2026

  • Who is the suspect in the WHCA dinner shooting?

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube